Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lexette (halobetasol propionate foam) / Mayne Pharma
NCT04571151: Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis	Not yet recruiting	4	30	US	LEXETTE 0.05% Topical Foam, Halobetasol Propionate Topical Foam, Sorilux 0.005 % Topical Foam, Calcipotriol Foam, Vehicle Foam	Skin Sciences, PLLC	Plaque Psoriasis	11/21	12/21